Palmatine (oral administration; 50 or 100 mg/kg, 7 days) has less distortion of epithelium, and fewer infiltrations of inflammatory cells, resulting in significantly lower histopathological scores, it also significantly suppresses the colonic MPO activity.
Animal Model: |
DSS- induced Colitis BALB/c mice model |
Dosage: |
50 or 100 mg/kg; 7 days |
Administration: |
Oral administration |
Result: |
Ameliorated DSS-induced colitis and prevented infiltration of inflammatory cells. |